Search

Search Constraints

You searched for: Author/Creator Drilon, A

Search Results

1. 105PDetection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292. (23rd October 2018)

2. 365ODurability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer. (24th November 2019)

3. 366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours. (24th November 2019)

4. 409OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. (23rd October 2018)

6. 69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. (25th November 2018)

7. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. (24th May 2019)

9. PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers. (27th August 2018)

10. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected. (10th March 2018)